2007LeukemiaRequires access

A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

Beatríz Bellosillo, Luz Martínez‐Avilés, Eva Gimeno, Lourdes Florensa, Raquel Longarón, Gemma Navarro, Antonio Salar, Blanca Espinet, Françesc Solé, S. Serrano, Carlos Besses

Open publisher page 23 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Essential thrombocythemia, Myelofibrosis, Polycythemia vera, clone (Java method), Janus kinase 2, JAK2 V617F, Platelet, Polycythemia rubra vera

Related papers

Back to paper searchBrowse research topicsOriginal source
A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis — Research Paper | ScholarLens